HC Wainwright & Co. Reiterates Buy on Rallybio, Maintains $17 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Rallybio (NASDAQ:RLYB) and maintained a $17 price target for the company's stock.
November 29, 2023 | 11:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Rallybio and maintained a $17 price target, potentially influencing investor confidence and the stock's performance.
The reiteration of a Buy rating and maintenance of a price target by a reputable analyst can lead to increased investor confidence and a positive short term impact on Rallybio's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100